{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-25-003374","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2025-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.842619+00:00","generated_at":"2026-05-17T05:43:04.774533+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Silexion Therapeutics regains Nasdaq compliance; subject to one-year monitor","bullets":["Received Nasdaq compliance letter on Sep 23, 2025 for equity (≥$2.5M) and minimum bid price ($1.00) requirements.","Financing transactions increased shareholders' equity by $10.3M to ~$9.41M as of Sep 15, 2025.","1-for-15 reverse stock split on Jul 29, 2025 brought bid price above $1.00.","Subject to mandatory panel monitor until Sep 23, 2026; any future non-compliance may lead to immediate delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-25-003374","json":"https://secwatch.observer/filing/0001178913-25-003374.json","markdown":"https://secwatch.observer/filing/0001178913-25-003374.md","text":"https://secwatch.observer/filing/0001178913-25-003374.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003374/0001178913-25-003374-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003374/zk2533805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:43:04.774533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}